Concepedia

Dirk Schepmann

DS

125

Publications

3.5K

Citations

33

H-Index

2001

Active since

Affiliations

University of Münster(Current)

University of Trieste

University of Pavia

Helmholtz-Zentrum Dresden-Rossendorf

Nagoya University

Dirk Schepmann is an author at University of Münster specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2001–2022

125

Publications

125

Bivalent β-Carbolines as Potential Multitarget Anti-Alzheimer Agents

Yvonne Rook, Kai-Uwe Schmidtke, Friedemann Gaube et al. · Journal of Medicinal Chemistry · 2010 · 133 citations · Full text

Improvement of σ1 receptor affinity by late-stage C–H-bond arylation of spirocyclic lactones

Christina Meyer, Benedikt Neue, Dirk Schepmann et al. · Bioorganic & Medicinal Chemistry · 2013 · 112 citations · Full text

, , +7

Quality and Functionality of Saffron: Quality Control, Species Assortment and Affinity of Extract and Isolated Saffron Compounds to NMDA and σ<sub>1</sub>(Sigma-1) Receptors

Matthias Lechtenberg, Dirk Schepmann, Michael Niehues et al. · Planta Medica · 2008 · 101 citations

Sila‐Haloperidol, a Silicon Analogue of the Dopamine (D <sub>2</sub> ) Receptor Antagonist Haloperidol: Synthesis, Pharmacological Properties, and Metabolic Fate

Reinhold Tacke, Friedrich Popp, Bárbara Müller et al. · ChemMedChem · 2007 · 95 citations

Synthesis and pharmacological evaluation of like- and unlike-configured tetrahydro-2-benzazepines with the α-substituted benzyl moiety in the 5-position

Peer Hasebein, Bastian Frehland, Kirstin Lehmkuhl et al. · Organic & Biomolecular Chemistry · 2014 · 75 citations

Rows per page

1–5 of 125